Table 2.
Subgroup analyses of all sleep indexes.
| Sleep indexs | Variable | No. of studies | Sample size | SMD (95%CI) | Test for overall effect | Heterogeneity | p value for subgroup difference | ||
|---|---|---|---|---|---|---|---|---|---|
| Z | p value | I2 | p value | ||||||
| PSQI | Country | 0.27 | |||||||
| US | 5 | 107 | −1.05 (−1.89, −0.21) | 2.44 | 0.01 | 72% | <0.01 | ||
| Other countries | 4 | 278 | −0.45 (−1.11, 0.22) | 1.32 | 0.19 | 85% | <0.01 | ||
| The number of participants | 0.37 | ||||||||
| <50 | 6 | 130 | −0.93 (−1.60, −0.25) | 2.69 | <0.01 | 66% | 0.01 | ||
| ≥50 | 3 | 255 | −0.44 (−1.25, 0.38) | 1.05 | 0.29 | 90% | <0.01 | ||
| Duration | 0.97 | ||||||||
| <4 weeks | 5 | 225 | −0.73 (−1.53, 0.07) | 1.79 | 0.07 | 84% | <0.01 | ||
| ≥4 weeks | 4 | 160 | −0.76 (−1.57, 0.06) | 1.82 | 0.07 | 79% | <0.01 | ||
| Total sleep time | Country | 0.26 | |||||||
| US | 3 | 79 | −0.20 (−0.69, 0.29) | 0.79 | 0.43 | 15% | 0.31 | ||
| Other countries | 3 | 246 | 0.12 (−0.13, 0.38) | 0.94 | 0.35 | 4% | 0.35 | ||
| The number of participants | 0.26 | ||||||||
| <50 | 3 | 79 | −0.20 (−0.69, 0.29) | 0.79 | 0.43 | 15% | 0.31 | ||
| ≥50 | 3 | 246 | 0.12 (−0.13, 0.38) | 0.94 | 0.35 | 4% | 0.35 | ||
| Duration | 0.5 | ||||||||
| <4 weeks | 2 | 165 | 0.16 (−0.31, 0.63) | 0.67 | 0.50 | 52% | 0.15 | ||
| ≥4 weeks | 4 | 160 | −0.04 (−0.38, 0.31) | 0.22 | 0.83 | 12% | 0.33 | ||
| Sleep efficiency | Country | 0.67 | |||||||
| US | 3 | 79 | 0.20 (−0.51, 0.90) | 0.54 | 0.59 | 57% | 0.10 | ||
| Other countries | 2 | 194 | 0.03 (−0.25, 0.31) | 0.21 | 0.83 | 0% | 0.77 | ||
| The number of participants | 0.67 | ||||||||
| <50 | 3 | 79 | 0.20 (−0.51, 0.90) | 0.54 | 0.59 | 57% | 0.10 | ||
| ≥50 | 2 | 194 | 0.03 (−0.25, 0.31) | 0.21 | 0.83 | 0% | 0.77 | ||
| Duration | 0.55 | ||||||||
| <4 weeks | 1 | 113 | −0.01 (−0.37, 0.36) | 0.03 | 0.98 | NA | NA | ||
| ≥4 weeks | 4 | 160 | 0.17 (−0.27, 0.61) | 0.76 | 0.45 | 40% | 0.17 | ||
NA, Not available.